Pmgc Holdings Inc. (ELAB) Stock Price & Analysis
Pmgc Holdings Inc. (ELAB) rose 1.54% to USD 5.29 as of September 8, 2026 at 14:49 UTC, according to Nexqual real-time market data.
ELAB last closed at USD 5.21; the session ranged USD 5.11–5.29 on volume of 7,332 shares. Market capitalization is $4.28M, with a 52-week range of USD 4.97–2,671.2 (NCM). Source: Nexqual, September 8, 2026 at 14:49 UTC.
Key Statistics (as of September 8, 2026 at 14:49 UTC)
| Price | USD 5.29 |
|---|---|
| Change | ▲ 1.54% (up) |
| Previous Close | USD 5.21 |
| Open | USD 5.21 |
| Day Range | USD 5.11 – 5.29 |
| 52-Week Range | USD 4.97 – 2,671.2 |
| Volume | 7,332 shares |
| Market Cap | $4.28M |
| Exchange | NCM |
Technical Analysis (ELAB)
Nexqual's technical model rates ELAB "SELL" based on 1 bullish and 5 bearish signals across 127 daily candles, as of September 8, 2026 at 14:49 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 30.22 (neutral) |
| vs SMA50 | Below (USD 8.91) |
| MACD | -1.24 (negative) |
Earnings (ELAB)
Source: Nexqual, September 8, 2026 at 14:49 UTC.
Financials & Fundamentals (ELAB)
| Total Revenue | $2.58M |
|---|---|
| Gross Margin | -20.51% |
| Operating Margin | -289.98% |
| Profit Margin | +0.00% |
| ROE | -105.22% |
| Debt / Equity | 85.07 |
| Current Ratio | 1.36 |
| Total Cash | $18.96M |
| Total Debt | $14.24M |
| Free Cash Flow | $-4.13M |
Source: Nexqual, September 8, 2026 at 14:49 UTC.
Ownership (ELAB)
| Insider Ownership | +5.61% |
|---|---|
| Institutional Ownership | +3.29% |
| Shares Outstanding | 809,579 |
| Float | 764,186 |
| Short % of Float | +3.28% |
Source: Nexqual, September 8, 2026 at 14:49 UTC.
Leadership (ELAB)
Pmgc Holdings Inc. is led by Graydon Bensler C.F.A. (age 33), CEO, CFO, Secretary & Director, per Nexqual as of September 8, 2026 at 14:49 UTC.
| CEO, CFO, Secretary & Director | Graydon Bensler C.F.A. (age 33) |
|---|
Major Backers & Investors (ELAB)
Notable institutional backers of Pmgc Holdings Inc. include Jane Street Group, LLC, Morgan Stanley, Fidelity, according to Nexqual as of September 8, 2026 at 14:49 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Jane Street Group, LLC | 1.01% |
| Morgan Stanley | 0.65% |
| Fidelity | 0.3% |
| Citadel | 0.26% |
| Virtu Financial LLC | 0.21% |
| Xtx Topco Ltd | 0.17% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 0.63% |
| Geode Capital | 0.3% |
Source: Nexqual, September 8, 2026 at 14:49 UTC.
From Pmgc Holdings Inc.'s Latest SEC 10-K Filing (filed 2026-03-30)
Key Strengths & Strategy (as disclosed to the SEC)
- We believe that the FDA will regulate part of our product candidates as a biologic drug (i.e., a biologic) through the Biologics License Application ("BLA") process under the jurisdiction of the Office of Therapeutic Products within the Center for Biologics Evaluation and Research ("CBER").
- Key operational and technical features include:             6   Competition   The precision machining and specialty metals CNC market is competitive and includes both small niche shops and larger, vertically integrated manufacturers.
- We compete with both domestic and international packaging providers, some of which have substantially greater resources than we do.   AGA Precision Systems — Precision Manufacturing   The precision machining and specialty metals CNC market is competitive and includes both small niche machine shops and larger, vertically integrated manufacturers.
- Our key competitive advantages include:           Sales and Marketing   As a diversified holding company, our sales and marketing activities are conducted both at the parent level and through our wholly owned subsidiaries, with strategies tailored to the specific industries in which each subsidiary operates.
Partnerships
- The Company aspires to either complete an IND submission in 2026, assuming it has sufficient working capital, or to enter into a collaboration with another company to do so.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ATPC | Agape ATP Corporation | USD 2.43 | ▲ 1.63% |
| NIVF | NewGenIvf Group Limited | USD 1.1 | ▼ 6.78% |
| TNON | Tenon Medical, Inc. | USD 3.2 | ▼ 15.12% |
| XPON | Expion Energy, Inc. | USD 5.51 | ▼ 11.13% |
| BDRX | Biodexa Pharmaceuticals plc | USD 0.85 | ▲ 6.89% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 14:49 UTC. This page is informational and not investment advice.